Hollencrest Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$556K Buy
1,151
+890
+341% +$236K 0.04% 208
2026
Q1
$28.6K Buy
261
+41
+19% +$5.84K ﹤0.01% 665
2025
Q4
$36.6K Sell
220
-364
-62% -$60.9K ﹤0.01% 615
2025
Q3
$114K Buy
+584
New +$96K ﹤0.01% 412
2025
Q2
Sell
-284
Closed -$16.9K 1215
2025
Q1
$16.9K Sell
284
-866
-75% -$80.1K ﹤0.01% 704
2024
Q4
$152K Buy
1,150
+650
+130% +$61K 0.01% 337
2024
Q3
$26.2K Buy
+500
New +$23.5K ﹤0.01% 620

Other funds holding ALAB

Hollencrest Capital Management's ALAB Position: Q2 2026 in Review

Hollencrest Capital Management increased its Astera Labs (ALAB) stake by 341% in Q2 2026, buying an estimated $236K and bringing the position to 1,151 shares worth $556K. The position accounts for 0.04% of the portfolio, ranked #208.

Hollencrest Capital Management first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Hollencrest Capital Management held 1,151 shares of Astera Labs worth $556K as of Q2 2026.
  • Hollencrest Capital Management bought 890 Astera Labs shares in Q2 2026, an estimated $236K.
  • Astera Labs made up 0.04% of Hollencrest Capital Management's portfolio in Q2 2026, its #208 holding.
  • Hollencrest Capital Management first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.